Acute rhabdomyolysis associated with cerivastatin therapy

Archives of Internal Medicine

Volumn 161, Issue 6, 2001, Pages 893-

  Garcia Valdecasas Campelo, E ^a   Gonzalez Reimers, E ^a   Lopez Lirola, A ^a   Rodriguez Rodriguez, E ^a   Santolaria Fernandez, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CERIVASTATIN; CREATINE KINASE MB; CREATININE; GEMFIBROZIL; HYPOCHOLESTEROLEMIC AGENT; MEVINOLIN; PRAVASTATIN; RHEUMATOID FACTOR; SIMVASTATIN;

AGED; ARTICLE; CASE REPORT; CREATININE CLEARANCE; FEMALE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; MYOPATHY; PRIORITY JOURNAL; RHABDOMYOLYSIS; SYMPTOMATOLOGY;

EID: 0035953117     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.6.893     Document Type: Article

References (5)

1. An overview of lipid-lowering drags
2. HMG-CoA reductase inhibitors: Current clinical experience
3. Extending therapy options in treating lipid disorders: A clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor
4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
5. Precliinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor